Bleeding is associated with intravenous immunoglobulin and therapeutic plasma exchange use in heparin-induced thrombocytopenia: A propensity matched analysis.

Loading...
Thumbnail Image

Date

2021-08

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

7
views
4
downloads

Citation Stats

Abstract

Intravenous immunoglobulin (IVIG) and therapeutic plasma exchange (TPE) are used in select cases with heparin-induced thrombocytopenia (HIT). In a cross-sectional analysis, a propensity matched sample was generated by IVIG or TPE treatment status to assess the primary outcome of mortality. In 500 HIT cases, IVIG or TPE was not associated with increased mortality (OR = 1.46; 95% CI: 0.81-2.63, p = 0.2052) but was associated with a higher likelihood of major bleeding (OR = 1.75; 95% CI: 1.03-2.96, p = 0.0376). The use of IVIG or TPE in HIT cases with bleeding contraindications to standard therapies should be further investigated.

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.1002/jha2.211

Publication Info

Soares Ferreira Júnior, Alexandre, Stephen H Boyle, Maragatha Kuchibhatla and Oluwatoyosi A Onwuemene (2021). Bleeding is associated with intravenous immunoglobulin and therapeutic plasma exchange use in heparin-induced thrombocytopenia: A propensity matched analysis. EJHaem, 2(3). pp. 466–470. 10.1002/jha2.211 Retrieved from https://hdl.handle.net/10161/27012.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

Onwuemene

Oluwatoyosi Adefunke Onwuemene

Associate Professor of Medicine

Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.